Corporate Investment in Prediction Markets Unwavering Despite Regulatory Uncertainty NGEN Q3 2025 Earnings NarrowerThanExpected Loss Per Share Amid Ongoing Clinical Development Phreesia Reports Fiscal First Quarter 2027 Financial Results